Shares of SMITHS GRP PLC/S (OTCMKTS:SMGZY) have received a consensus rating of “Hold” from the seven research firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company.
A number of analysts have commented on SMGZY shares. JPMorgan Chase & Co. restated a “neutral” rating on shares of SMITHS GRP PLC/S in a research report on Friday, September 21st. Goldman Sachs Group restated a “neutral” rating on shares of SMITHS GRP PLC/S in a research report on Thursday, October 4th. Finally, Royal Bank of Canada downgraded shares of SMITHS GRP PLC/S from an “outperform” rating to an “underperform” rating in a research report on Tuesday.
SMITHS GRP PLC/S stock traded down $0.22 during midday trading on Friday, reaching $17.66. 115,092 shares of the stock traded hands, compared to its average volume of 80,744. The company has a quick ratio of 1.56, a current ratio of 2.04 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $7.08 billion, a price-to-earnings ratio of 14.60, a PEG ratio of 1.91 and a beta of 1.01. SMITHS GRP PLC/S has a fifty-two week low of $16.26 and a fifty-two week high of $24.42.
Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.
Featured Article: How to calculate the annual rate of depreciation
Receive News & Ratings for SMITHS GRP PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SMITHS GRP PLC/S and related companies with MarketBeat.com's FREE daily email newsletter.